Castle Biosciences (CSTL) Net Margin Growth (3y) (2021 - 2026)
Castle Biosciences (CSTL) Net Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 191.00 |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -482.00 |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 3,350.00 |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 89.00 |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -237.00 |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 405.00 |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 3,776.00 |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 89.00 |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 178.00 |
| 10 | Castle Biosciences | 1.04 Bn | 773.13 Mn | 79.85 Mn | 3,546.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,546.00 |
| Mar 31, 2026 | 5,212.00 |
| Dec 31, 2025 | 5,110.00 |
| Sep 30, 2025 | 5,411.00 |
| Jun 30, 2025 | 1,002.00 |
| Mar 31, 2025 | 6,232.00 |
| Dec 31, 2024 | 6,455.00 |
| Sep 30, 2024 | 5,287.00 |
| Jun 30, 2024 | 4,888.00 |
| Mar 31, 2024 | 1,529.00 |
| Dec 31, 2023 | 2,436.00 |
| Sep 30, 2023 | 1,893.00 |
| Jun 30, 2023 | -2,663.00 |
| Mar 31, 2023 | -7,274.00 |
| Dec 31, 2022 | -6,543.00 |
| Sep 30, 2022 | -9,223.00 |
| Jun 30, 2022 | 1,636.00 |
| Mar 31, 2022 | -6,483.00 |
| Dec 31, 2021 | -7,847.00 |
| Sep 30, 2021 | 6,982.00 |